Hiroaki Tanaka
Direttore/Membro del Consiglio presso EneCoat Technologies Co., Ltd.
Provenienza dei contatti di primo grado di Hiroaki Tanaka
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
EneCoat Technologies Co., Ltd.
 EneCoat Technologies Co., Ltd. SemiconductorsElectronic Technology EneCoat Technologies Co., Ltd. is a company based in Kyoto, Japan that focuses on developing materials for perovskite solar cells and manufacturing modules. The Japanese company aims to promote the effective use of natural energy and protect the environment to create a better future. EneCoat Technologies Co. was founded in 2018 by Atsushi Wakamiya and Naoya Kato, with Naoya Kato serving as the CEO since then.
3
| Holding Company | Semiconductors | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Hiroaki Tanaka tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Kyoto University | College/University | Undergraduate Degree Undergraduate Degree | |
Kyoto University Innovation Capital Co., Ltd.
 Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Investment Managers | Private Equity Investor | |
Luxonus Co., Ltd.
 Luxonus Co., Ltd. Electronics/AppliancesConsumer Durables Luxonus Co., Ltd. manufactures photo acoustic imaging products. The company is based in Kawasaki, Japan. The Japanese company was founded by Sadakazu Aiso. | Electronics/Appliances | Director/Board Member | |
Rege Nephro Co. Ltd.
 Rege Nephro Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Rege Nephro Co. Ltd. is a company based in Kyoto, Japan that specializes in the research, development, production, and sales of renal disease treatment drugs. The Japanese company has developed a unique and realistic approach to induce high-efficiency differentiation from stem cells, with the aim of saving patients suffering from renal failure. The company's research and development activities focus on developing various solutions for renal disease and improving the quality of life of patients suffering from renal disease. Rege Nephro Co. was founded in 2019 by Kenji Nagafune. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
| Giappone | 5 |
Settori
| Consumer Services | 2 |
| Finance | 2 |
| Consumer Durables | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 5 |
| Founder | 2 |
| Undergraduate Degree | 2 |
| Private Equity Investor | 1 |
| Chief Executive Officer | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Osami Kono | 4 |
| Naoya Kato | 2 |
| Atsushi Wakamiya | 2 |
- Borsa valori
- Insiders
- Hiroaki Tanaka
- Connessioni Società
